Ibaraki, Japan

Yoshikuni Ito


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 1988-1989

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Yoshikuni Ito

Introduction

Yoshikuni Ito is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic applications. His work has led to the filing of multiple patents, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

Yoshikuni Ito holds 2 patents that focus on quinazoline derivatives. His latest patents include "Quinazoline derivatives and process for their production," which relates to compounds exhibiting aldose reductase-inhibitory activity. The invention details compounds of a specific formula where R¹ and R² can be hydrogen, halogen, lower alkoxy, or halo(lower)alkyl. Another patent is titled "Quinazoline derivatives, compositions thereof and their use in treating," which also describes compounds of a similar formula with potential therapeutic uses.

Career Highlights

Yoshikuni Ito is associated with Fujisawa Pharmaceutical Company, Ltd., where he has contributed to various research initiatives. His work has been instrumental in developing new pharmaceutical compounds that may offer significant health benefits.

Collaborations

Throughout his career, Yoshikuni Ito has collaborated with esteemed colleagues, including Masashi Hashimoto and Teruo Kyoto Oku. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Yoshikuni Ito's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to impact the development of new therapeutic compounds, showcasing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…